Founded in 1983, Pharmascience is a Canadian pharmaceutical company that employs over 1300 people. The third largest pharmaceutical firm in Canada in terms of the number of prescriptions, it sells its products in over 60 countries and posted sales of more than $700 million. Pharmascience has distinguished itself over the years due to its continued growth. It invest $30 million annually in research and development. In 2011, $40 million was invested to expand its facilities. It also acquired Aegera Therapeutics Inc., a company in the biotechnology sector. These milestones in the history of Pharmascience demostrate the will of the company to diversify its activities and ensure its long-term growth.